CompletedNot Applicable

Comparative Results After DSAEK, UT-DSAEK and DMEK for Fuchs Endothelial Corneal Dystophy

France218 participantsStarted 2017-08-01

Plain-language summary

Purpose of the research is to describe and compare the evolution of BSCVA after DMEK, DSAEK and UT-DSAEK for Fuchs Endothelial Corneal Dystrophy (FECD) and Moderate Pseudophakic Bullous Keratopathy (PBK). To secondarily research the correlates criterions with best spectacle corrected visual acuity (BSCVA) 12 months postoperatively.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients requiring posterior lamellar transplantation for FECD or moderate PBK, with preoperative BSCVA of less than 0.3 logmar, Exclusion Criteria: * Patients with pathologies that may seriously affect VA postoperatively

What they're measuring

visual acuity

Timeframe: 6 months

visual acuity

Timeframe: 12 months

visual acuity

Timeframe: 24 months

Trial details

NCT IDNCT04424550

SponsorCentre Hospitalier Régional Metz-Thionville

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-08-01

View on ClinicalTrials.gov More Corneal Dystrophy trials